Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Why Novartis’ $12bn Avidity bet suddenly looks more interesting after new del-brax data Find out how Novartis AG’s del-brax data could strengthen its $12bn Avidity Biosciences bet and rare muscle disease strategy. byPallavi MadhirajuJune 12, 2026